TY - JOUR
T1 - Revised waist circumference cut-off points for the criteria of abdominal obesity in the Spanish population
T2 - Multicenter nationwide Spanish population based study
AU - Martínez-Larrad, María Teresa
AU - Fernández-Pérez, Cristina
AU - Corbatón-Anchuelo, Arturo
AU - Gabriel, Rafael
AU - Lorenzo, Carlos
AU - Serrano-Ríos, Manuel
N1 - Funding Information:
This research was supported by grants from FIS (Fondo de Investigación Sanitario) 95/0029 , FEDER 2FD 1997/2309 from the European Regional Development Fund, Red de Centros RCMN ( C03/08 ), and FIS 03/1618, from Instituto de Salud Carlos III-RETIC RD06/0015/0012 , Madrid, Spain. CIBERDEM. Partial support also came from Fundation Mutua Madrileña ( FMM08 ), Educational Grants from Eli Lilly Lab , Spain and Bayer Pharmaceutical Co. , Spain; and DANONE Institute .
PY - 2011/9
Y1 - 2011/9
N2 - Aims: To investigate the optimal waist circumference (WC) cut-off points in the general Spanish-population and its relationships with insulin resistance (IR) and metabolic syndrome (MS) due to the disparity of values WC in the different regional areas. Methods: A multicenter nationwide Spanish population based study on 3844 unrelated subjects, aged 35-74 years. Receiver operating characteristic (ROC) curve was analysed to identify the optimal WC cut-off points for detecting metabolic abnormalities related to the MS. Results: The prevalence of MS, International Diabetes Federation (IDF) criteria: 29.1%/33.1% in males/females (P =.004), Adult Treatment Panel III (ATPIII) criteria: 23.5%/30.9% males/females (P <.001). Optimal WC cut-off to obtain the maximal sensitivity and specificity for detecting two or more of the other metabolic abnormalities associated with MS or IR was 94.5/89.5 cm in males/females. According to these cut-off points, the prevalence of abdominal-obesity was 57.2%/61.3% in males/females, P =.011 and prevalence of MS was similar in both genders (males/females: 27.9%/28.9%, P =.527). The Spearman correlation coefficient relating WC to HOMA IR was 0.395. IR was similarly prevalent in males/females 24.1%/21.7% (P <.088). Prevalence of IR was 43% in subjects with MS by IDF criteria. Conclusions: The new WC cut-off points found in our population were 94.5/89.5 cm for males/females. For males, the cut-off points were lower than those defined by ATPIII but similar to IDF criteria. For females these cut-off points were higher than those proposed by ATPIII/IDF criteria.
AB - Aims: To investigate the optimal waist circumference (WC) cut-off points in the general Spanish-population and its relationships with insulin resistance (IR) and metabolic syndrome (MS) due to the disparity of values WC in the different regional areas. Methods: A multicenter nationwide Spanish population based study on 3844 unrelated subjects, aged 35-74 years. Receiver operating characteristic (ROC) curve was analysed to identify the optimal WC cut-off points for detecting metabolic abnormalities related to the MS. Results: The prevalence of MS, International Diabetes Federation (IDF) criteria: 29.1%/33.1% in males/females (P =.004), Adult Treatment Panel III (ATPIII) criteria: 23.5%/30.9% males/females (P <.001). Optimal WC cut-off to obtain the maximal sensitivity and specificity for detecting two or more of the other metabolic abnormalities associated with MS or IR was 94.5/89.5 cm in males/females. According to these cut-off points, the prevalence of abdominal-obesity was 57.2%/61.3% in males/females, P =.011 and prevalence of MS was similar in both genders (males/females: 27.9%/28.9%, P =.527). The Spearman correlation coefficient relating WC to HOMA IR was 0.395. IR was similarly prevalent in males/females 24.1%/21.7% (P <.088). Prevalence of IR was 43% in subjects with MS by IDF criteria. Conclusions: The new WC cut-off points found in our population were 94.5/89.5 cm for males/females. For males, the cut-off points were lower than those defined by ATPIII but similar to IDF criteria. For females these cut-off points were higher than those proposed by ATPIII/IDF criteria.
KW - Abdominal obesity
KW - Metabolic syndrome
KW - Waist-circumference
UR - http://www.scopus.com/inward/record.url?scp=84855493386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855493386&partnerID=8YFLogxK
U2 - 10.1016/j.avdiab.2011.09.003
DO - 10.1016/j.avdiab.2011.09.003
M3 - Article
AN - SCOPUS:84855493386
SN - 1134-3230
VL - 27
SP - 168
EP - 174
JO - Avances en Diabetologia
JF - Avances en Diabetologia
IS - 5
ER -